Jordan Park

Jordan Park

Healthcare & Biotech Analyst

Healthcare and biotech analyst focused on pharma pipelines, medtech adoption curves, and reimbursement dynamics. Former clinical research coordinator and later equity research analyst. Writes thesis-driven pieces that connect clinical catalysts, competitive landscapes, and valuation scenarios.

Articles 769

Jan 13, 2026 Finance

Redwire Streamlines Operations with Unified Branding and New Business Structure

Corporate rebranding consolidates Edge Autonomy assets as Redwire sharpens focus on space and defense technology sectors

Redwire Corporation has announced the retirement of the Edge Autonomy name, consolidating its uncrewed aerial systems and related defense technologies...

Jan 13, 2026 Finance

Analysts Highlight Three Defensive Consumer Staples Stocks with Strong Dividend Yields

Top Analyst Ratings and Recent Developments for B&G Foods, Conagra Brands, and Altria Group

In periods marked by market volatility, investors often prioritize stocks with robust dividend yields, particularly those from companies exhibiting st...

Building and Using Trading Contingency Plans: A Step-by-Step Guide to Handling Unexpected Events in Stock Trading
Jan 13, 2026 Education

Building and Using Trading Contingency Plans: A Step-by-Step Guide to Handling Unexpected Events in Stock Trading

For beginner and intermediate traders seeking practical frameworks to prepare for market surprises and maintain discipline under uncertain conditions

Unexpected events in stock trading such as market volatility spikes, technical failures, or personal interruptions can disrupt your trading plan and l...

Jan 13, 2026 Finance

Synchronizing Growth and Momentum: A Robust Strategy to Identify Emerging Market Leaders

Leveraging multi-year performance and persistent price strength in small- and mid-cap stocks to uncover future industry frontrunners

Investors often view growth and momentum as opposing investment philosophies, yet combining their insights creates a powerful method for identifying c...

Jan 13, 2026 Trade Ideas

Buy the Dip in Centrus (LEU): A Risk-Weighted Swing Into HALEU Optionality

Quarterly noise, a bigger balance-sheet setup, and a policy-fueled market make the recent pullback an asymmetric trade.

Centrus' share price has pulled back after a bout of headline-driven selling. The business still earns most of its revenue from low-enriched uranium (...

Trade Idea Long
Jan 13, 2026 Trade Ideas

AST SpaceMobile: Betting on a Premium, Direct-to-Cell Play While Starlink Chases Scale

Actionable long idea - exposure to ASTS ahead of commercialization catalysts; entry, stops, and targets included.

AST SpaceMobile (ASTS) is building a space-based cellular broadband layer that connects directly to unmodified mobile phones. The business is still ea...

Trade Idea Long
Jan 13, 2026 Finance

Georgia Federal Court Moves Forward with Paragard IUD Trial Despite Teva's Requested Delay

Judge Leigh Martin May Upholds January Trial Date Amid Legal Battle Over Copper Contraceptive Device Safety Claims

A federal judge in Georgia has denied Teva Pharmaceutical Industries' request to postpone the first trial in a consolidated litigation concerning alle...

Jan 13, 2026 Finance

Aclarion Secures $10.4M Equity Financing to Accelerate Nociscan Development and Market Penetration

Funding bolsters company’s cash reserves, extends operational runway to 2028, and supports clinical and commercial scale-up efforts for its AI-driven imaging platform

Aclarion, Inc. recently completed a $10.4 million common stock equity raise, priced at $5.18 per share, strengthening its financial position as it adv...

Jan 13, 2026 Finance

Carbon Emissions Disproportionately Driven by Wealthiest 1% Amid Calls for Policy Reforms

Analysis Shows Top 0.1% Exhaust Their Carbon Budget Within Three Days, Highlighting Urgent Need for Targeted Climate Action

An assessment reveals that the planet's wealthiest 1% have consumed their entire per capita carbon emissions allowance for 2026 in just ten days, unde...

Jan 13, 2026 Finance

Concerns Grow Over China's Tech Market After Early 2026 Gains

Strong Rally in Chinese Tech Stocks Faces Early Signs of Overheating and Margin Risks

Chinese equity markets began 2026 with impressive gains driven by enthusiasm around technology and AI advancements. However, by Tuesday, signs emerged...